At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.Job Description Key ResponsibilitiesChina Development StrategyStrategic Development LeadershipContribute to the development and execution of China clinical development strategies for assigned assets and indications.Evaluate China's treatment landscape, epidemiology, unmet medical needs, competitive environment, and evolving standards of care to identify development opportunities.Provide scientific and clinical recommendations regarding China participation in global development programs.Assess the need for China-specific studies, bridging strategies, dose justification, and registration pathways.Influence global development plans to optimize simultaneous global and China registration.Support portfolio evaluation, lifecycle management, and business development assessments from a clinical perspective.External Environment AssessmentMaintain deep understanding of emerging clinical data, competitive intelligence, treatment guidelines, and evolving regulatory expectations in China.Establish and maintain strong relationships with key opinion leaders (KOLs), investigators, cooperative groups, and academic institutions.Identify opportunities for investigator engagement and scientific collaboration to support development objectives.Medical Monitoring and Clinical Trial OversightMedical MonitoringServe as Medical Monitor for assigned clinical studies.Provide ongoing medical oversight to ensure subject safety and scientific integrity.Review subject eligibility, protocol deviations, and significant medical events.Perform individual patient-level and aggregate data review.Evaluate efficacy, safety, laboratory, PK/PD, biomarker, and patient-reported outcome data.Identify data trends impacting risk-benefit assessment or development decisions.Lead medical review activities during interim analyses and database locks.Participate in safety review meetings, dose escalation discussions, DMC/IDMC meetings, and study governance committees.Respond to investigator inquiries regarding protocol interpretation, eligibility criteria, patient management, and safety issues.Provide the ongoing clinical training to the study team, CRO partners, etc.Safety SurveillanceConduct ongoing review of SAE, AESI, deaths, and emerging safety signals.Collaborate with Patient Safety and Pharmacovigilance teams in benefit-risk assessment.Ensure timely identification, escalation, and management of potential safety concerns.Contribute to safety narratives, aggregate safety reviews, DSURs, and regulatory responses.Clinical Science LeadershipLead or contribute to protocol development, study concept design, and protocol amendments.Review and approve key clinical documents including:ProtocolsInvestigator BrochuresInformed Consent FormsStatistical Analysis PlansRisk mitigation plansClinical Study ReportsEnsure scientific rigor and medical relevance of development programs.Scientific CommunicationPresent clinical data to internal governance bodies and development teams.Review or contribute to abstracts, manuscripts, conference presentations, publications and advisory board materials, etc.Represent the company in scientific interactions with investigators, KOLs, and external experts.Regulatory Strategy and Health Authority InteractionsRegulatory SupportProvide clinical support for:Pre-IND/IND submissionsPre-NDA/BLA, NDA/BLA submissionsHealth authority meetingsRegulatory briefing packagesResponses to regulatory questionsCollaborate with Regulatory Affairs to develop China registration strategies.Participate in interactions with NMPA/CDE and other regulatory agencies as required.Support development of benefit-risk arguments and clinical justification packages.Cross-Functional LeadershipServe as the clinical representative on global and regional project teams.Collaborate closely with:Clinical OperationsRegulatory AffairsProject ManagementBiostatisticsPatient SafetyClinical PharmacologyBiomarker and DiagnosticsMedical AffairsProvide strategic clinical guidance to study teams and CRO partners.QualificationsEducationMD or equivalent medical degree required.Specialty training in Oncology, Hematology, Immunology, Hepatology, or other relevant therapeutic areas preferred.ExperienceMD with 5+ years of pharmaceutical industry and/or clinical research experience.Demonstrated experience as a Medical Monitor or Clinical Research Physician.Experience supporting and leading Phase I-III regional or global clinical development programs.Track record of successful regulatory interactions and major submissions.Demonstrated contributions to development strategy and portfolio decision-making.Prior experience as a practicing physician is a plus.Preferred CompetenciesScientific LeadershipStrong understanding of:drug developmentclinical trial methodologyoncology/immunology/inflammation therapeutic areastranslational medicinebiomarker-driven developmentStrategic ThinkingAbility to integrate the following into development strategy:medical needregulatory requirementscompetitive intelligencecommercial considerationsRegulatory ExpertiseStrong knowledge of:ICH-GCPNMPA/CDE regulationsFDA regulationsEMA regulationsLeadership and InfluenceAbility to influence global development decisions without direct authority.Excellent communication, stakeholder management, and matrix leadership skills. 临床开发副总监/总监（肿瘤/炎症方向）职位概述临床开发副总监/总监（肿瘤/炎症方向）将负责为相关治疗领域内的临床开发项目及临床研究提供医学与科学领导力。该岗位将同时承担医学监查职责，并作为中国开发策略的核心贡献者，推动全球开发目标与中国临床实践、监管要求及竞争环境有效衔接。该岗位将在药物开发全生命周期中提供战略性科学输入，负责监督受试者安全、医学数据质量及关键临床决策支持；同时与全球、区域及中国跨职能团队紧密协作，支持产品在中国的高质量开发、注册申报及上市路径推进。1.中国临床开发策略战略制定与开发领导主导或参与制定并执行所负责资产及适应症的中国临床开发策略。系统评估中国疾病负担、治疗格局、未满足医疗需求、竞争态势及治疗标准变化，识别并推动潜在开发机会。就中国参与全球开发项目提供临床、科学及注册策略方面的专业建议。评估中国特异性研究、桥接策略、剂量合理性论证及注册路径的必要性与可行性。影响并优化全球开发计划，促进全球与中国开发及注册进程的协同推进。从临床开发视角支持产品组合评估、生命周期管理及业务发展相关医学评估。外部环境洞察与学术合作持续跟踪中国及全球新兴临床数据、竞争情报、诊疗指南及监管趋势，并将相关洞察转化为开发策略输入。建立并维护与关键意见领袖（KOL）、研究者、协作组及学术机构的专业合作关系。识别研究者参与、科学合作及外部专家咨询机会，以支持临床开发目标达成2.医学监查与临床研究监督医学监查职责担任所负责临床研究的医学监查员，提供全程医学监督与科学支持。保障受试者安全、研究执行质量及临床数据的科学完整性。审阅受试者入排标准符合性、方案偏离、重要医学事件及关键临床判断事项。开展个体受试者层面及汇总层面的医学数据审阅，识别潜在临床趋势和风险信号。综合评估疗效、安全性、实验室检查、PK/PD、生物标志物及患者报告结局等关键数据。识别可能影响获益-风险评估、研究推进或开发决策的数据趋势。在期中分析、数据清理和数据库锁定阶段，领导或支持医学审阅相关工作。参与安全性审阅会议、剂量递增讨论、DMC/IDMC会议以及研究治理委员会会议。回应研究者关于方案解读、入组标准、患者管理及安全性事项的医学咨询。为研究团队、研究中心及CRO合作伙伴提供持续医学培训和临床指导。安全性监测与获益-风险评估持续审阅SAE、AESI、死亡事件及新出现的安全性信号。与患者安全、药物警戒及相关职能团队协作，开展持续获益-风险评估。确保潜在安全性问题得到及时识别、升级、沟通和管理。参与安全性叙述、汇总安全性审阅、DSUR及监管问询回复等医学内容的撰写和审阅。临床科学领导与文件审阅领导或参与研究概念设计、方案制定、方案修订及关键研究设计决策。审阅并批准关键临床及医学文件，包括但不限于：研究方案研究者手册知情同意书统计分析计划风险缓解计划临床研究报告确保临床开发项目具备充分的科学严谨性、医学合理性及可执行性。科学沟通与外部交流向内部治理委员会、项目团队及开发决策机构汇报临床数据、医学判断及关键风险。审阅或参与摘要、论文、会议报告、医学发表及顾问委员会材料等科学沟通内容的撰写。代表公司与研究者、KOL及外部专家开展高质量科学交流。3.注册策略与药政沟通支持注册申报与药政互动为以下注册相关活动提供医学和临床开发支持：Pre-IND/IND申报Pre-NDA/BLA、NDA/BLA申报药政机构会议监管沟通资料包监管问题回复与注册事务团队紧密合作，制定并优化中国注册策略及临床开发路径。根据项目需要，参与与NMPA/CDE及其他监管机构的沟通准备和会议讨论。支持获益-风险论证、临床合理性说明及监管问题回复中医学内容的制定。跨职能协作与团队领导作为临床开发代表参与全球、区域及中国项目团队，推动关键医学和开发决策。与以下职能团队保持高效协作，确保项目科学性、执行质量和注册目标的实现：临床运营注册事务项目管理生物统计患者安全临床药理生物标志物与诊断医学事务为研究团队、研究中心及CRO合作伙伴提供战略性临床指导，推动研究高质量执行。任职要求教育背景医学博士（MD）或同等医学学位，具备扎实的医学和临床科学背景。具有肿瘤学、血液学、免疫学、肝病学或其他相关治疗领域专科培训背景者优先。工作经验具备5年以上制药行业、临床开发和/或临床研究相关经验。具有医学监查员、临床研究医生或临床开发医生相关岗位经验。具备支持及领导I-III期区域或全球临床开发项目的实际经验。具有参与监管沟通、关键注册申报或重大里程碑项目的成功经验。能够在开发策略制定、产品组合评估或项目决策中提供清晰且有影响力的临床输入。具有既往临床执业医生经验者优先。核心能力科学与临床领导力深入理解药物开发及临床研究方法学，并熟悉以下领域：药物开发临床试验方法学肿瘤/免疫/炎症治疗领域转化医学生物标志物驱动的开发战略思维具备全局视角和战略判断力，能够将以下因素整合到临床开发策略中：医疗需求监管要求竞争情报商业考量法规专业能力熟悉临床开发相关法规、指导原则及监管实践，包括但不限于：ICH-GCPNMPA/CDE法规要求FDA法规要求EMA法规要求领导力与影响力能够在矩阵式组织中有效影响全球及区域开发决策，即使在无直接汇报关系的情况下也能推动共识形成。具备优秀的沟通表达、利益相关方管理、跨文化协作和矩阵式领导能力。For Current Gilead Employees and Contractors:Please apply via the Internal Career Opportunities portal in Workday.